Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: Recent clinically relevant findings from DRCR.net Protocol T

Sophie Cai, Neil M. Bressler

Research output: Contribution to journal › Review article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: Recent clinically relevant findings from DRCR.net Protocol T'. Together they form a unique fingerprint.

Medicine & Life Sciences